Cipher Pharmaceuticals Inc. today announced that the United States Patent and Trademark Office has issued a Patent Notice of Allowance for CIP-ISOTRETINOIN, the Company's novel formulation of the acne medication isotretinoin.
By the time you're done with this area you should accept a acceptable abstraction of the science abaft abscess and feel assured in how you would like to proceed.
Saturday, June 7, 2008
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment